Clinical Trials Logo

Hypoxemia clinical trials

View clinical trials related to Hypoxemia.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05479929 Active, not recruiting - Cough Clinical Trials

Work of Breathing Assessment in Triage Scale

Start date: October 30, 2020
Phase:
Study type: Observational

The proposed research study will be a prospective observational study designed to validate the Canadian Triage Assessment Scale (CTAS) in regard to work of breathing in patients in the emergency department. The investigators will assess inter-rater agreement between nurses & emergency physicians for assessment of work of breathing.

NCT ID: NCT04708340 Active, not recruiting - COVID-19 Clinical Trials

Tolerability and Efficacy of RJX in Patients With COVID-19

RJX
Start date: March 25, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

This study is designed as a 2-part, 2-cohort, double-blind, randomized, placebo controlled, multicenter Phase 1/2 study to evaluate the safety, tolerability and efficacy of RJX in patients with COVID-19.

NCT ID: NCT02440919 Active, not recruiting - Hypoxemia Clinical Trials

Oxygen Supplementation and Ventilator Hyperinflation in the Endotracheal Suction (OSVHES)

OSVHES
Start date: June 2013
Phase: N/A
Study type: Interventional

This is a double crossover study where all patients are randomly allocated to one of two treatment sequences associated with endotracheal aspiration.The first treatment (A) uses two suctioning methods for each patient: one involving hyperoxygenation with administration of 100% oxygen 1 minute before and after suction (intervention I), and the other hyperoxygenation with oxygen supply to 20% above basal offer (Intervention II) in the same way.The second treatment (B) uses a technique of hyperinflation with the mechanical ventilator (PEEP-ZEEP) associated with hyperoxygenation. The intervention I, uses PEEP-ZEEP offering 20% above basal oxygenation and intervention II uses the PEEP-ZEEP with basal oxygen supply in the same way. All subjects were randomly allocated using sealed envelopes to a treatment sequence A or B on Day 1. Patients received two treatments, at least four hours apart. The first treatment is in the morning and the alternate treatment is performed in the afternoon. On Day 2 the order of the treatments was reversed using the same patient position sequence.The interventions I and II are performed at least 4 hours apart to minimize any carryover effect.